TY  - GEN 
AU  - García-Lozano, María del Rosario
AU  - Rodríguez-Martínez, Alejandro
AU  - Rodríguez-Martínez
PY  - 2023
UR  - https://hdl.handle.net/10481/81350
AB  - Since 2011 Direct Acting antivirals (DAAs) drugs targeting different non-structural (NS) viral proteins (NS3, NS5A or NS5B inhibitors) have been approved for clinical use in HCV therapies. However, currently there are not licensed therapeutics to...
LA  - eng
PB  - Elsevier
KW  - Flavivirus
KW  - NS3 protease
KW  - Small molecules inhibitors
KW  - Privileged structures
KW  - Acyl and urea piperazine derivatives
KW  - Live virus phenotypic assay
KW  - Molecular docking
KW  - Molecular modeling
TI  - Piperazine-derived small molecules as potential Flaviviridae NS3 protease  inhibitors. In vitro antiviral activity evaluation against Zika and  Dengue viruses
DO  - 10.1016/j.bioorg.2023.106408
ER  -